@article{9a3cd62fafee4ce4bfe2d489a79ec2c9,
title = "Phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results",
author = "Y. Kagawa and H. Satake and T. Kato and K. Oba and H. Yasui and M. Nakamura and T. Watanabe and K. Hirata and K. Muro and Y. Komatsu and T. Yoshino and K. Yamazaki and H. Mishima and M. Kotaka and A. Tsuji and Y. Kakeji and E. Oki and N. Nagata and S. Junichi",
year = "2018",
month = nov,
day = "1",
doi = "10.1093/annonc/mdy431.021",
language = "English",
volume = "29",
pages = "ix34--ix35",
journal = "Annals of oncology : official journal of the European Society for Medical Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
}
